Search
for
Sort by
Research 151–180 of 1000+
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Spectroscopic determination of the minoxidil drug by charge transfer complex using Schiff base
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- From Sea to Therapy: Marine Biomaterials for Drug Delivery and Wound Healing
- Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
- Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Recent Insights into the Potential and Challenges of Sericin as a Drug Delivery Platform for Multiple Biomedical Applications
- The effect of platelet-derived growth factor-aa (PDGFA) conjugated with low-molecular-weight protamine (LMWP) on hair loss improvement effect
- Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications
- Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- Cedrol in ginger (Zingiber officinale) as a promising hair growth drug: The effects of oral and external administration on hair regeneration and its mechanism
- A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Comparative analysis of 3D and 2D cell-culturing methods in hair follicle spheroid morphogenesis and drug responsiveness
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Analysis of Dermal Papilla Cell Interactome Using STRING Database to Profile the ex Vivo Hair Growth Inhibition Effect of a Vinca Alkaloid Drug, Colchicine
- Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments
- Topical delivery of nanoemulsions for skin cancer treatment
- Bioinspired Polymers: Transformative Applications in Biomedicine and Regenerative Medicine
- Stimuli-Sensitive Nanocarriers for Diagnostic and Therapy
- Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim
- Development and Characterization of Thiolated Cyclodextrin-Based Nanoparticles for Topical Delivery of Minoxidil
- Recent Advances in Biodegradable and Biocompatible Synthetic Polymers Used in Skin Wound Healing
- Magnetic coiffure: Engineering of human hair surfaces with polyelectrolyte-stabilised magnetite nanoparticles
- Intracrine androgen biosynthesis, metabolism and action revisited